Cardiovascular Health

Teva Pharmaceutical Industries recently launched generic versions of Sanofi's enoxaparin sodium injection (Lovenox) and Pfizer's linezolid injection (Zyvox).

The clinical risk calculators incorporated into dyslipidemia treatment guidelines may overestimate a patient's risk of experiencing a cardiovascular event.

A paper from a pair of physicists may reveal significant new information about the causes of atrial fibrillation and help to make cardiac ablations a more effective treatment for the condition.

Gastroesophageal reflux disease and atrial fibrillation are 2 of the most significant health concerns in the United States, and researchers suspect a link between them.

Prescribing methods for a newer atrial fibrillation agent require more monitoring to improve patient safety in community hospitals.

Several studies have reported that controlling blood pressure with medication improves cardiovascular outcomes.

The FDA has granted 510(k) clearance to Silk Road Medical's Enroute Transcarotid Neuroprotection System (TNS), a first-in-class device to restore normal blood flow to narrowed carotid arteries during carotid angioplasty and stenting.

Daiichi Sankyo today announced the US launch of edoxaban, a once-daily anti-clotting agent indicated for reducing the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation.

New research published in the British Medical Journal has answered some of the most basic questions about treating hypertension.

Despite having adequate knowledge on cardiovascular risk factors, pharmacists and other health care professionals showed significant increases in systemic arterial hypertension and excessive weight gain across a 20-year study.

One in three people say they would risk living a shorter life instead of taking a daily pill to prevent cardiovascular disease, according to new research inCirculation: Cardiovascular Quality and Outcomes.

What's keeping insomniacs awake at night might also be raising their blood pressure.

Reducing elevated blood pressure during pregnancy is safe for the expectant mother and her child.

A primary goal of managing atrial fibrillation is relief of symptoms that include dizziness, fatigue, palpitations, shortness of breath, and chest pain. Yet, it is symptomless in up to one-third of patients.

Women diagnosed with polycystic ovary syndrome are more likely to develop heart disease, diabetes, and other chronic conditions than those without the hormone disorder.

Improved care for HIV-infected patients within the Kaiser Permanente system has essentially reversed their previously reported increased heart attack risk.

Avocados may help reduce low-density lipoprotein cholesterol.

Use of anticoagulants in atrial fibrillation patients remains unacceptably low, with some estimates showing that only half of patients receive anticoagulants as indicated by current treatment guidelines.

One of the most common questions from prescribers that I have answered in the past year concerns how to convert from 1 anticoagulant to anothe

Not every patient requires an aspirin a day.

Preliminary results of an ongoing post-marketing study examining Janssen Pharmaceuticals' rivaroxaban (Xarelto) in patients with non-valvular atrial fibrillation (NVAF) indicate that the anti-clotting drug's safety in real-world settings is consistent with the findings of previous phase 3 clinical trials.

Children with favorable psychosocial experiences may have better cardiovascular health in adulthood.

Roughly 50 million Americans take daily low-dose aspirin for cardioprevention, as it is generally perceived as a safe, effective, and inexpensive OTC preventive medication for cardiovascular disease. For patients who have nonvalvular atrial fibrillation, many guidelines recommend aspirin as thromboprophylaxis among those who are not considered to be high risk.

A collaborative, pharmacist-led intervention targeted at health care professionals improves statin prescribing and lowers the risk of atherosclerotic events in patients with cardiovascular disease.

With proper treatment, individuals with atrial fibrillation can live normal and active lives.

With proper treatment, individuals with atrial fibrillation can live normal and active lives.

Scientists from the Diabetes Research Centre at the University of Leicester have identified a link between low blood glucose levels and adverse cardiovascular events in patients with diabetes.

New research posits that cocaine use quadruples the risk of sudden cardiovascular death among individuals aged 19 to 49 years.

Many people experience a slight quivering or racing heart at some point and usually give it little notice. But for those diagnosed with atrial fibrillation, that irregular heartbeat can be a serious condition that can increase the risk of stroke and needs medical attention.

Various health organizations promote the importance of maintaining cardiovascular health because cardiovascular disease (CVD) is the leading cause of death among both men and women in the United States and the number of individuals with CVD continues to escalate annually.